Viewing StudyNCT00358566



Ignite Creation Date: 2024-05-05 @ 4:57 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00358566
Status: TERMINATED
Last Update Posted: 2008-05-19
First Post: 2006-07-14

Brief Title: GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Sponsor: Pharmexa AS
Organization: Pharmexa AS

Conditions & Keywords Data

Conditions:
Name
Advanced Unresectable Pancreatic Cancer
Keywords:
Name View
Pancreatic cancer View
Advanced View
Unresesctable View
Adenocarcinoma View